BACKGROUND: Cardiac remodelling after acute myocardial infarction (AMI) is characterised by molecular and cellular mechanisms involving both left and right ventricles, and biventricular failure identifies patients with an extremely unfavourable prognosis. AIMS: To assess whether a link exists between increased myocardial apoptotic rates (AR) at sites of recent infarction and patterns of unfavourable cardiac remodelling, such as biventricular enlargement after left ventricular (LV) infarction. METHODS: Twelve patients with recent AMI involving the LV and not the right ventricle (RV) and with permanent infarct related artery occlusion were selected at necropsy. Gross pathological characteristics, such as LV and RV dilatation, and AR at site of infarction were assessed. Potential false positive results (DNA synthesis and RNA splicing) were excluded from the cell count. RESULTS: RV enlargement, defined as a tricuspidal ring greater than 120 mm, was found in five cases and was associated with LV dilatation. These patients showed significantly higher AR than the others. When the subjects were divided into three groups according to progressive cardiac remodelling (absence of cardiac dilatation, isolated LV dilatation, and biventricular enlargement), the last group had significantly higher ARs than the other two groups, showing that myocardiocyte apoptosis is increased in more unfavourable forms of cardiac remodelling. CONCLUSION: Patients with severely unfavourable cardiac remodelling, such as biventricular enlargement, have extremely high myocardiocyte apoptosis at necropsy, even late after LV myocardial infarction, supporting the role of myocardiocyte loss in determining post-infarction adverse remodelling.
BACKGROUND:Cardiac remodelling after acute myocardial infarction (AMI) is characterised by molecular and cellular mechanisms involving both left and right ventricles, and biventricular failure identifies patients with an extremely unfavourable prognosis. AIMS: To assess whether a link exists between increased myocardial apoptotic rates (AR) at sites of recent infarction and patterns of unfavourable cardiac remodelling, such as biventricular enlargement after left ventricular (LV) infarction. METHODS: Twelve patients with recent AMI involving the LV and not the right ventricle (RV) and with permanent infarct related artery occlusion were selected at necropsy. Gross pathological characteristics, such as LV and RV dilatation, and AR at site of infarction were assessed. Potential false positive results (DNA synthesis and RNA splicing) were excluded from the cell count. RESULTS: RV enlargement, defined as a tricuspidal ring greater than 120 mm, was found in five cases and was associated with LV dilatation. These patients showed significantly higher AR than the others. When the subjects were divided into three groups according to progressive cardiac remodelling (absence of cardiac dilatation, isolated LV dilatation, and biventricular enlargement), the last group had significantly higher ARs than the other two groups, showing that myocardiocyte apoptosis is increased in more unfavourable forms of cardiac remodelling. CONCLUSION:Patients with severely unfavourable cardiac remodelling, such as biventricular enlargement, have extremely high myocardiocyte apoptosis at necropsy, even late after LV myocardial infarction, supporting the role of myocardiocyte loss in determining post-infarction adverse remodelling.
Authors: S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: A Ecarnot-Laubriet; M Assem; F Poirson-Bichat; M Moisant; C Bernard; S Lecour; E Solary; L Rochette; J-R Teyssier Journal: Biochim Biophys Acta Date: 2002-04-24
Authors: F Sam; D B Sawyer; D L Chang; F R Eberli; S Ngoy; M Jain; J Amin; C S Apstein; W S Colucci Journal: Am J Physiol Heart Circ Physiol Date: 2000-07 Impact factor: 4.733
Authors: A A Kocher; M D Schuster; M J Szabolcs; S Takuma; D Burkhoff; J Wang; S Homma; N M Edwards; S Itescu Journal: Nat Med Date: 2001-04 Impact factor: 53.440
Authors: M Metzger; M L Higuchi; L F Moreira; M J F Chaves; J B Castelli; J M L Silvestre; E Bocchi; N Stolf; J A Ramires Journal: Eur J Clin Invest Date: 2002-06 Impact factor: 4.686
Authors: Antonio Abbate; Rossana Bussani; Giuseppe G L Biondi-Zoccai; Raffaele Rossiello; Furio Silvestri; Feliciano Baldi; Luigi M Biasucci; Alfonso Baldi Journal: Circulation Date: 2002-08-27 Impact factor: 29.690
Authors: D Santini; A Abbate; S Scarpa; F Vasaturo; G G Biondi-Zoccai; R Bussani; F De Giorgio; F Bassan; D Camilot; M P Di Marino; F Feroce; F Baldi; F Silvestri; F Crea; A Baldi Journal: J Clin Pathol Date: 2004-12 Impact factor: 3.411
Authors: Antonio Abbate; Rossana Bussani; Gianfranco Sinagra; Elena Barresi; Alberto Pivetta; Andrea Perkan; Nicholas H Hoke; Fadi N Salloum; Michael C Kontos; Giuseppe G L Biondi-Zoccai; George W Vetrovec; Gastone Sabbadini; Feliciano Baldi; Furio Silvestri; Rakesh C Kukreja; Alfonso Baldi Journal: Am J Cardiol Date: 2008-06-17 Impact factor: 2.778
Authors: Ivanita Stefanon; María Valero-Muñoz; Aurélia Araújo Fernandes; Rogério Faustino Ribeiro; Cristina Rodríguez; Maria Miana; José Martínez-González; Jessica S Spalenza; Vicente Lahera; Paula F Vassallo; Victoria Cachofeiro Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240
Authors: Stefano Toldo; Herman J Bogaard; Benjamin W Van Tassell; Eleonora Mezzaroma; Ignacio M Seropian; Roshanak Robati; Fadi N Salloum; Norbert F Voelkel; Antonio Abbate Journal: PLoS One Date: 2011-03-24 Impact factor: 3.240